<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="ppr-dysp" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">ppr-dysp</book-part-id>
      <title-group>
        <title>Progressive Pseudorheumatoid Dysplasia</title>
        <alt-title alt-title-type="alt-title">Synonyms: Progressive Pseudorheumatoid Arthropathy of Childhood, Progressive Pseudorheumatoid Chondrodysplasia, SEDT-PA, Spondyloepiphyseal Dysplasia Tarda with Progressive Arthropathy</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bhavani</surname>
            <given-names>Gandham SriLakshmi</given-names>
          </name>
          <degrees>MSc</degrees>
          <email>gslbhavani@gmail.com</email>
          <aff>Department of Medical Genetics<break/>Kasturba Medical College<break/>Manipal University<break/>Manipal, India</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shah</surname>
            <given-names>Hitesh</given-names>
          </name>
          <degrees>MS</degrees>
          <email>hiteshshah12@gmail.com</email>
          <aff>Pediatric Orthopedics Services<break/>Department of Orthopedics<break/>Kasturba Medical College<break/>Manipal University<break/>Manipal, India</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shukla</surname>
            <given-names>Anju</given-names>
          </name>
          <degrees>MD, DM</degrees>
          <email>dranju2003@yahoo.co.in</email>
          <aff>Department of Medical Genetics<break/>Kasturba Medical College<break/>Manipal University<break/>Manipal, India</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dalal</surname>
            <given-names>Ashwin</given-names>
          </name>
          <degrees>MD, DM</degrees>
          <email>adalal@cdfd.org.in</email>
          <aff>Diagnostics Division <break/>Centre for DNA Fingerprinting and Diagnostics<break/>Hyderabad, India</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Girisha</surname>
            <given-names>Katta Mohan</given-names>
          </name>
          <degrees>MD, DM</degrees>
          <email>girish.katta@manipal.edu</email>
          <aff>Department of Medical Genetics<break/>Kasturba Medical College<break/>Manipal University<break/>Manipal, India</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2015-11-25" date-type="created">
          <day>25</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="lafora" document-type="chapter">Progressive Myoclonus Epilepsy, Lafora Type</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="prolidase-def" document-type="chapter">Prolidase Deficiency</related-object>
      <abstract id="ppr-dysp.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Progressive pseudorheumatoid dysplasia (PPD) is a skeletal dysplasia characterized by predominant involvement of articular cartilage with progressive joint stiffness and enlargement in the absence of inflammation. Onset &#x02013; typically between ages three and six years &#x02013; begins with the involvement of the interphalangeal joints. Over time, involvement of large joints and the spine causes significant joint contractures, gait disturbance, and scoliosis and/or kyphosis, resulting in abnormal posture and significant morbidity. Despite the considerable arthropathy, pain is not a major presenting feature of this condition.</p>
          <p>Initially height is normal; however, short stature (&#x0003c;3<sup>rd</sup> centile) becomes evident in adolescence as the skeletal changes progress.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Although radiologic examination has high accuracy in the diagnosis of PPD, the definitive diagnosis is established in a proband with identification of the characteristic radiologic findings and biallelic pathogenic variants in <italic toggle="yes">WISP3</italic> on molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Treatment is supportive. Pain due to secondary osteoarthritis may respond to NSAIDs. Other anti-inflammatory medications may have limited efficacy in the treatment, but are best avoided in view of their significant side effects. Physical therapy may help preserve joint mobility. Surgical intervention, including realignment of the lower limbs, joint arthroplasty, and/or treatment of spinal stenosis may be necessary.</p>
          <p><italic toggle="yes">Surveillance:</italic> Monitoring for orthopedic complications including bone deformity, secondary joint disease, spinal deformities, and pain.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Immobilization (such as casting).</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Deformities of the pelvis may necessitate delivery by c&#x000e6;sarean section.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>PPD is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if both <italic toggle="yes">WISP3</italic> pathogenic variants have been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="ppr-dysp.Diagnosis">
        <title>Diagnosis</title>
        <p>Progressive pseudorheumatoid dysplasia (PPD) is a distinctive form of spondyloepiphyseal dysplasia with predominant joint disease.</p>
        <p>Formal diagnostic criteria are lacking at present.</p>
        <sec id="ppr-dysp.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Progressive pseudorheumatoid dysplasia <bold>should be suspected</bold> in individuals with the following clinical and radiologic findings.</p>
          <p>Clinical features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Healthy at birth</p>
            </list-item>
            <list-item>
              <p>Onset of arthropathy early in childhood, usually between ages three and six years</p>
            </list-item>
            <list-item>
              <p>Enlargement of interphalangeal joints of hands (<xref ref-type="fig" rid="ppr-dysp.F1">Figure 1</xref>)</p>
            </list-item>
            <list-item>
              <p>Progressive restricted mobility of all joints</p>
            </list-item>
            <list-item>
              <p>Gait abnormalities</p>
            </list-item>
            <list-item>
              <p>Genu valgum/ genu varum</p>
            </list-item>
            <list-item>
              <p>Progressive hip disease (commonly coxa vara at the late stage)</p>
            </list-item>
            <list-item>
              <p>Articular pain</p>
            </list-item>
            <list-item>
              <p>Motor weakness and fatigability</p>
            </list-item>
            <list-item>
              <p>Spine involvement in late childhood and adolescence with thoracolumbar kyphoscoliosis that leads to short trunk</p>
            </list-item>
            <list-item>
              <p>Adult height below the 3<sup>rd</sup> percentile</p>
            </list-item>
            <list-item>
              <p>Absence of signs of inflammation</p>
            </list-item>
            <list-item>
              <p>Normal erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels</p>
            </list-item>
          </list>
          <p><bold>Radiologic features include</bold> spondyloepiphyseal dysplasia, generalized arthropathy, distinctive joint deformity of the hands (superficially resembling that of juvenile idiopathic arthritis), and diffuse osteoporosis at the late stage.</p>
          <p><bold>Hands</bold> show enlarged epiphyses, widened metaphyses, and loss of or narrow joint spaces in the metacarpophalangeal and interphalangeal joints, particularly in the proximal interphalangeal joints (<xref ref-type="fig" rid="ppr-dysp.F2">Figure 2</xref>) [<xref ref-type="bibr" rid="ppr-dysp.REF.dalal.2012.2820">Dalal et al 2012</xref>]. Camptodactyly is always present in adulthood.</p>
          <p><bold>Pelvis.</bold> Hips show enlarged and flattened capital femoral epiphyses and short and wide femoral necks (<xref ref-type="fig" rid="ppr-dysp.F3">Figure 3</xref>) [<xref ref-type="bibr" rid="ppr-dysp.REF.dalal.2012.2820">Dalal et al 2012</xref>, <xref ref-type="bibr" rid="ppr-dysp.REF.garcia_segarra.2012.217">Garcia Segarra et al 2012</xref>]. Broadened ilia and irregular acetabular roofs are observed (<xref ref-type="fig" rid="ppr-dysp.F3">Figure 3</xref>).</p>
          <p><bold>Spine.</bold> Progressive irregularities in the ossification of vertebral end plates and platyspondyly with loss or narrowing of intervertebral disc spaces are observed in all (<xref ref-type="fig" rid="ppr-dysp.F4">Figure 4</xref>). Anterior beaking of the vertebral bodies is seen in preadolescents [<xref ref-type="bibr" rid="ppr-dysp.REF.garcia_segarra.2012.217">Garcia Segarra et al 2012</xref>].</p>
          <p><bold>Shoulders and knees.</bold> Osteophytic formations and periarticular calcifications can be seen.</p>
        </sec>
        <sec id="ppr-dysp.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>In general, radiologic examination is highly accurate in the diagnosis of PPD. The diagnosis of progressive pseudorheumatoid dysplasia <bold>is confirmed</bold> in a proband with identification of biallelic pathogenic variants in <italic toggle="yes">WISP3</italic> on molecular genetic testing (see <xref ref-type="table" rid="ppr-dysp.T.molecular_genetic_testing_use">Table 1</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing,</bold> use of a <bold>multi-gene panel,</bold> and <bold>genomic testing.</bold></p>
          <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">WISP3</italic> is performed first. If only one or no pathogenic variant is found, sequence analysis of cDNA from cultured skin fibroblasts may be performed to detect splicing aberrations resulting from intronic pathogenic variants [<xref ref-type="bibr" rid="ppr-dysp.REF.garcia_segarra.2012.217">Garcia Segarra et al 2012</xref>] (see <xref ref-type="sec" rid="ppr-dysp.Molecular_Genetics">Molecular Genetics</xref>).</p>
          <p>Targeted analysis for pathogenic variants can include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>c.156C&#x0003e;A (p.Cys52Ter) is the most frequent pathogenic variant in Turkish patients and accounts for approximately 28% of pathogenic variants worldwide [Author, review of the literature].</p>
            </list-item>
            <list-item>
              <p>c.1010G&#x0003e;A (p.Cys337Tyr) and c.233G&#x0003e;A (p.Cys78Tyr) are the most common pathogenic variants in the Indian population.</p>
            </list-item>
          </list>
          <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">WISP3</italic> and other genes of interest (see <xref ref-type="sec" rid="ppr-dysp.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time.</p>
          <p><bold>More comprehensive genomic testing</bold> including whole-exome sequencing (WES) and (when available) whole-genome sequencing (WGS) may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">WISP3</italic>) fails to confirm a diagnosis in an individual with features of PPD. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation.</p>
          <p>For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
          <table-wrap id="ppr-dysp.T.molecular_genetic_testing_use" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Progressive Pseudorheumatoid Dysplasia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ppr-dysp.T.molecular_genetic_testing_use_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_ppr-dysp.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_ppr-dysp.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Characteristic Radiographic Findings in Whom Pathogenic Variants&#x000a0;<sup>2</sup> are Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ppr-dysp.T.molecular_genetic_testing_use_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">WISP3</italic>
                  </td>
                  <td headers="hd_h_ppr-dysp.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_ppr-dysp.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Nearly 100%&#x000a0;<sup>4</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="ppr-dysp.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="ppr-dysp" object-id="ppr-dysp.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="ppr-dysp.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="ppr-dysp.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="ppr-dysp.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="ppr-dysp.TF.1.4">
                <label>4. </label>
                <p>Among the pathogenic variants were three intronic variant alleles identified by fibroblast cDNA sequence analysis; two of the three are deep intronic pathogenic variants [<xref ref-type="bibr" rid="ppr-dysp.REF.garcia_segarra.2012.217">Garcia Segarra et al 2012</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="ppr-dysp.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="ppr-dysp.Clinical_Description">
          <title>Clinical Description</title>
          <p>Progressive pseudorheumatoid dysplasia (PPD) is a skeletal dysplasia characterized by predominant involvement of articular cartilage with progressive joint stiffness and enlargement, and the absence of signs of inflammation [<xref ref-type="bibr" rid="ppr-dysp.REF.dalal.2012.2820">Dalal et al 2012</xref>]. Progression of the disease severely affects gait and posture and causes significant morbidity.</p>
          <p>PPD does not have any extraskeletal manifestations, such as craniofacial features or cognitive involvement.</p>
          <sec id="ppr-dysp.Clinical_Features">
            <title>Clinical Features</title>
            <p><bold>Onset.</bold> Children with PPD are normal at birth and during infancy. The age of onset is typically between three and six years [<xref ref-type="bibr" rid="ppr-dysp.REF.wynnedavies.1982.442">Wynne-Davies et al 1982</xref>, <xref ref-type="bibr" rid="ppr-dysp.REF.garcia_segarra.2012.217">Garcia Segarra et al 2012</xref>]; the range is from one year to 16 years [<xref ref-type="bibr" rid="ppr-dysp.REF.delague.2005.118">Delague et al 2005</xref>, <xref ref-type="bibr" rid="ppr-dysp.REF.dalal.2012.2820">Dalal et al 2012</xref>].</p>
            <p>Initial presenting features in the majority are interphalangeal joint swelling, pain, and gait abnormalities. Joint deformities become manifest over time. Joint pain is rarely the presenting symptom and is disproportionately mild to the severity of arthropathy.</p>
            <p><bold>Joints.</bold> Enlargement, stiffness, and restricted range of movement in the hands start in the proximal interphalangeal joints and progress to the distal interphalangeal joints (<xref ref-type="fig" rid="ppr-dysp.F1">Figure 1</xref>) [<xref ref-type="bibr" rid="ppr-dysp.REF.garcia_segarra.2012.217">Garcia Segarra et al 2012</xref>]. These joints develop progressive contractures.</p>
            <p>The joint enlargement, stiffness, and restricted range of movement gradually involve all large joints (i.e., knees, hips, wrists, and elbows) [<xref ref-type="bibr" rid="ppr-dysp.REF.dalal.2012.2820">Dalal et al 2012</xref>, <xref ref-type="bibr" rid="ppr-dysp.REF.garcia_segarra.2012.217">Garcia Segarra et al 2012</xref>]. Hip involvement commonly manifests as coxa vara later in the disease course. The knees show either genu varum or genu valgum. Typically, the shoulder joints are not severely affected [<xref ref-type="bibr" rid="ppr-dysp.REF.dalal.2012.2820">Dalal et al 2012</xref>].</p>
            <p><bold>Spine.</bold> Scoliosis and/or kyphosis are noted in a majority of affected individuals during adolescence. Lordosis may also be seen. The neck is only occasionally involved [<xref ref-type="bibr" rid="ppr-dysp.REF.dalal.2012.2820">Dalal et al 2012</xref>].</p>
            <p><bold>Height.</bold> Height is initially normal; however, short stature becomes evident as the skeletal changes progress. Adult height is typically below the 3rd centile [<xref ref-type="bibr" rid="ppr-dysp.REF.garcia_segarra.2012.217">Garcia Segarra et al 2012</xref>]. Flexion deformities at the hips and knees as well as spinal changes contribute in part to the short stature.</p>
          </sec>
        </sec>
        <sec id="ppr-dysp.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No genotype-phenotype correlations have been observed.</p>
          <p>Mild variation in age of onset, severity, and progression noted in different families is not explained by the type of pathogenic variants or their locations.</p>
          <p>Intrafamilial variation has been observed [<xref ref-type="bibr" rid="ppr-dysp.REF.bhavani.2015.2481">Bhavani et al 2015</xref>].</p>
        </sec>
        <sec id="ppr-dysp.Nomenclature">
          <title>Nomenclature</title>
          <p>The name progressive <bold>pseudorheumatoid</bold> dysplasia reflects its resemblance to juvenile rheumatoid arthritis.</p>
          <p>PPD was previously referred to as spondyloepiphyseal dysplasia with progressive arthropathy.</p>
        </sec>
        <sec id="ppr-dysp.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of PPD has been estimated at one per million in the United Kingdom (prevalence category of &#x0003c;1-9:1,000,000) [<xref ref-type="bibr" rid="ppr-dysp.REF.wynnedavies.1982.442">Wynne-Davies et al 1982</xref>]. However, the disease may be underdiagnosed due to the overlap of clinical features with juvenile idiopathic arthritis. To date more than 160 families with molecularly confirmed PPD have been reported.</p>
          <p>PPD is more frequent in endogamic communities [<xref ref-type="bibr" rid="ppr-dysp.REF.delague.2005.118">Delague et al 2005</xref>, <xref ref-type="bibr" rid="ppr-dysp.REF.dalal.2012.2820">Dalal et al 2012</xref>]. The largest series has been published from India [<xref ref-type="bibr" rid="ppr-dysp.REF.dalal.2012.2820">Dalal et al 2012</xref>, <xref ref-type="bibr" rid="ppr-dysp.REF.bhavani.2015.2481">Bhavani et al 2015</xref>].</p>
          <p>PPD has been observed among populations with a high rate of consanguinity in Kuwait, Lebanon, Iran, Jordan, Saudi Arabia, Syria, Palestine, and Morocco.</p>
        </sec>
      </sec>
      <sec id="ppr-dysp.Genetically_Related_Allelic_Dis">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">WISP3</italic>.</p>
      </sec>
      <sec id="ppr-dysp.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Juvenile idiopathic arthritis and all skeletal dysplasias with epiphyseal and spondylar involvement are to be considered in the differential diagnosis of progressive pseudorheumatoid dysplasia (PPD).</p>
        <p><bold>Juvenile idiopathic arthritis (JIA)</bold> is the disorder most commonly confused with PPD. The main differentiating features:</p>
        <list list-type="bullet">
          <list-item>
            <p>Joint inflammation (tenderness and warmth) in JIA</p>
          </list-item>
          <list-item>
            <p>Elevation of ESR and CRP in JIA and not in PPD. However, in some instances elevation of these acute reactants in JIA can be minimal.</p>
          </list-item>
          <list-item>
            <p>In JIA, joint destruction seen on radiographs. In PPD radiographs show dysplasia along with epiphyseal enlargement and platyspondyly.</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="sedt" document-type="chapter"><bold>X-linked spondyloepiphyseal dysplasia tarda</bold></related-object> (X-linked SEDT) develops in adolescence or adulthood and is characterized by disproportionate short stature, platyspondyly with a distinctive posterior hump of the vertebral bodies, and osteoarthritis without involvement of peripheral joints. X-linked SEDT is caused by mutation of <italic toggle="yes">TRAPPC2</italic> (<italic toggle="yes">SEDL</italic>).</p>
        <p><bold>In the mucopolysaccharidoses (MPSs)</bold> the vertebral deformities (hook-shaped vertebral bodies with inferior beaking or platyspondyly with central beaking) and progressive joint limitation are similar to those of PPD. Extraskeletal manifestations observed in the MPSs (such as coarse facies, corneal clouding, hepatomegaly, and intellectual disability) are not present in PPD. (See <related-object link-type="booklink" source-id="gene" document-id="mps1" document-type="chapter">MPS I</related-object>, <related-object link-type="booklink" source-id="gene" document-id="hunter" document-type="chapter">MPS II</related-object>, <related-object link-type="booklink" source-id="gene" document-id="mps4a" document-type="chapter">MPS IV A</related-object>, MPS IVB, and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS607014">Mucopolysaccharidoses: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.)</p>
        <p>Atypical forms of <italic toggle="yes">COL2A1</italic>-related spondyloepiphyseal dysplasias may share features of PPD:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Czech dysplasia</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609162">609162</ext-link>), also called progressive pseudorheumatoid dysplasia with hypoplastic toes, is characterized by early onset osteoarthritis and hypoplastic 3<sup>rd</sup>, 4<sup>th</sup> and 5<sup>th</sup> toes. Radiologic features (including platyspondyly with irregular endplates and usually anterior-posteriorly elongated vertebral bodies, coxa vara, short femoral neck, and narrow joint spaces) resemble those of PPD. However, normal stature and short postaxial toes in Czech dysplasia are distinguishable features. Czech dysplasia is caused by heterozygous pathogenic variants in <italic toggle="yes">COL2A1</italic> (usually the p.Arg275Cys pathogenic variant) and is inherited in an autosomal dominant manner.</p>
          </list-item>
          <list-item>
            <p><bold>Spondyloepimetaphyseal dysplasia, Strudwick type</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/184250">184250</ext-link>) shares some features with PPD. Individuals with this condition are very short and present in infancy. Spondyloepimetaphyseal dysplasia, Strudwick type is caused by mutation of <italic toggle="yes">COL2A1</italic> and is inherited in an autosomal dominant manner.</p>
          </list-item>
        </list>
        <p><bold>Spondylometaphyseal dysplasia corner fracture type</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/184255">184255</ext-link>), also known as Sutcliffe type may resemble some phenotypic variants of PPD [unpublished data].</p>
      </sec>
      <sec id="ppr-dysp.Management">
        <title>Management</title>
        <sec id="ppr-dysp.Evaluations_Following_Initial_D">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with progressive pseudorheumatoid dysplasia (PPD), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete skeletal survey, if not already done as part of the diagnostic evaluation</p>
            </list-item>
            <list-item>
              <p>Referral to a pediatric orthopedic surgeon or specialist in treating bone dysplasias</p>
            </list-item>
            <list-item>
              <p>Consultation with a medical geneticist and/or genetic counselor or a multidisciplinary skeletal dysplasia team</p>
            </list-item>
          </list>
        </sec>
        <sec id="ppr-dysp.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Treatment is supportive. No specific therapy for PPD is available.</p>
          <p>Pain due to secondary osteoarthritis may respond to NSAIDs. Other anti-inflammatory medications including steroids and immunosuppressive drugs (cyclosporine and methotrexate) have a limited role in treatment and are best avoided in view of their significant side effects.</p>
          <p>Physical therapy may help preserve joint mobility. Immobilization (e.g., casting) should be avoided.</p>
          <p>Most joint involvement requires intervention by an orthopedist and/or physical therapist.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Angular deformities of lower limbs.</bold> The indications for surgical correction are to restore normal alignment of the lower limbs and to alleviate gait disturbance, instability, and/or pain.</p>
            </list-item>
            <list-item>
              <p>
                <bold>Progressive joint stiffness</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Large joint stiffness is managed by physical therapy, activity modification, and walking aids.</p>
                </list-item>
                <list-item>
                  <p>Small joint arthropathy is managed by an occupational therapist who may advise adaptive devices, modification of activity, and/or vocational training.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Joint pain.</bold> Severe joint pain due to advanced osteoarthritis is treated by joint arthroplasty (i.e., hip and knee replacement). Early hip replacement (second decade of life) can be successful in relieving pain and restoring the ability to ambulate.</p>
            </list-item>
            <list-item>
              <p>
                <bold>Progressive stiffness and deformities of the spine</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Scoliosis and mild kyphosis can be managed with bracing.</p>
                </list-item>
                <list-item>
                  <p>Spinal canal stenosis can be managed with decompression, fusion, and instrumentation.</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="ppr-dysp.Surveillance">
          <title>Surveillance</title>
          <p>No specific guidelines for surveillance have been published.</p>
          <p>Recommendations include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Monitoring for orthopedic complications including bone deformity, secondary joint disease, spinal deformities, and pain</p>
            </list-item>
            <list-item>
              <p>Evaluation by a specialist in skeletal dysplasia or a multidisciplinary skeletal dysplasia clinic every year</p>
            </list-item>
          </list>
        </sec>
        <sec id="ppr-dysp.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Avoid immobilization (e.g., casting).</p>
        </sec>
        <sec id="ppr-dysp.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="ppr-dysp.Related_Genetic_Counseling_Issu">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="ppr-dysp.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Deformities of pelvis may necessitate delivery by c&#x000e6;sarean section in pregnant women who have PPD.</p>
        </sec>
        <sec id="ppr-dysp.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="ppr-dysp.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="ppr-dysp.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Progressive pseudorheumatoid dysplasia (PPD) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="ppr-dysp.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">WISP3</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with PPD are obligate heterozygotes for a pathogenic variant in <italic toggle="yes">WISP3</italic>.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">WISP3</italic> pathogenic variant.</p>
        </sec>
        <sec id="ppr-dysp.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">WISP3</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="ppr-dysp.Related_Genetic_Counseling_Issu">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="ppr-dysp.Prenatal_Testing_and_Preimplant">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">WISP3</italic> pathogenic variants have been identified in an affected family member, prenatal testing or preimplantation genetic diagnosis for a pregnancy at increased risk for progressive pseudorheumatoid dysplasia may be an option that a couple may wish to consider.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="ppr-dysp.Resources">
        <title>Resources</title>
      </sec>
      <sec id="ppr-dysp.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="ppr-dysp.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">WISP3</italic> consists of five exons. Ensembl lists 11 transcripts, produced as a result of alternative splicing (GRCh38). The most commonly used and clinically relevant reference sequence is <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003880.3">NM_003880.3</ext-link> with a length of 1,235 bp. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="ppr-dysp" object-id="ppr-dysp.molgen.TA">Table A</related-object>, <bold>Gene</bold></p>
          <p><bold>Pathogenic allelic variants.</bold> More than 60 pathogenic variants have been reported in <italic toggle="yes">WISP3</italic>. Missense variants, deletions, nonsense variants, duplications, and splice site variants as well as complex variants such as indels have been described. Additionally, two deep intronic missense variant alleles that caused alternative splicing were identified in fibroblast cDNA [<xref ref-type="bibr" rid="ppr-dysp.REF.garcia_segarra.2012.217">Garcia Segarra et al 2012</xref>].</p>
          <p>The most common pathogenic variant observed across all ethnicities is p.Cys52Ter (~28%).</p>
          <p>Two other pathogenic variants observed only in the Indian population are p.Cys337Tyr in exon 5 and p.Cys78Tyr in exon 2.</p>
          <table-wrap id="ppr-dysp.T.wisp3_pathogenic_variants_dis" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p><italic toggle="yes">WISP3</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ppr-dysp.T.wisp3_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_ppr-dysp.T.wisp3_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                  <th id="hd_h_ppr-dysp.T.wisp3_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ppr-dysp.T.wisp3_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.156C&#x0003e;A</td>
                  <td headers="hd_h_ppr-dysp.T.wisp3_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys52Ter</td>
                  <td headers="hd_h_ppr-dysp.T.wisp3_pathogenic_variants_dis_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003880.3">NM_003880.3</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_003871.1">NP_003871.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ppr-dysp.T.wisp3_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.233G&#x0003e;A</td>
                  <td headers="hd_h_ppr-dysp.T.wisp3_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys78Tyr</td>
                </tr>
                <tr>
                  <td headers="hd_h_ppr-dysp.T.wisp3_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1010G&#x0003e;A</td>
                  <td headers="hd_h_ppr-dysp.T.wisp3_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys337Tyr</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">WISP3</italic> encodes a 354-amino acid protein, Wnt1 inducible signaling pathway protein 3 (WISP-3), of approximately 40-kd molecular weight. WISP-3 comprises five functional domains: peptide signal sequence, insulin-like growth factor binding proteins (IGF-BP) like domain, von Willebrand factor type C (VWC) repeat domain, thrombospondin type I domain, and cysteine knot domain [<xref ref-type="bibr" rid="ppr-dysp.REF.hurvitz.1999.94">Hurvitz et al 1999</xref>].</p>
          <p>WISP-3 is a member of the CCN (connective tissue growth factor/cysteine-rich61/nephroblastoma overexpressed) family of growth factors [<xref ref-type="bibr" rid="ppr-dysp.REF.pennica.1998.14717">Pennica et al 1998</xref>]. WISP-3 regulates type II collagen and aggrecan expression by the activation of SOX9 transcription factors [<xref ref-type="bibr" rid="ppr-dysp.REF.sen.2004.488">Sen et al 2004</xref>] and plays a major role in cartilage homeostasis by inhibiting cell proliferation and promoting precursor cell differentiation of chondrocytes [<xref ref-type="bibr" rid="ppr-dysp.REF.wang.2013">Wang et al 2013</xref>].</p>
          <p><bold>Abnormal gene product.</bold> The pathophysiology of <italic toggle="yes">WISP3</italic> variants resulting in PPD is not completely understood. However, studies show that WISP-3 expression is significantly reduced in the chondrocytes of individuals with PPD [<xref ref-type="bibr" rid="ppr-dysp.REF.zhou.2007.985">Zhou et al 2007</xref>]. Mutant articular chondrocytes with very low levels of WISP-3 expression show an increased rate of proliferation, increased cell viability, and decreased apoptosis suggesting that they are in an immature and hyper-proliferative state, which may explain the enlarged metaphyses observed in individuals with PPD. Mutant WISP-3 shows abnormal aggregation in the cytoplasm and cell membrane of chondrocytes [<xref ref-type="bibr" rid="ppr-dysp.REF.wang.2013">Wang et al 2013</xref>]. As mutant WISP-3 delays intracellular collagen synthesis and inhibits extracellular collagen secretion, the cartilage flexibility in individuals with PPD diminishes.</p>
          <p><bold>Cancer and benign tumors.</bold> Loss or downregulation of WISP-3 is associated with breast cancers, colorectal cancers, and hepatocellular carcinoma as reduction of WISP-3 stimulates tumorigenesis. The COSMIC (Catalogue of Somatic Mutations in Cancer) database shows 45 unique <italic toggle="yes">WISP3</italic> variants in tissues associated with cancers.</p>
        </sec>
      </sec>
      <sec id="ppr-dysp.References">
        <title>References</title>
        <sec id="ppr-dysp.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="ppr-dysp.Literature_Cited.reflist0">
            <ref id="ppr-dysp.REF.bhavani.2015.2481">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bhavani</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalal</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shukla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aggarwal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phadke</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gowrishankar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhat</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puri</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bijarnia-Mahay</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nampoothiri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohanasundaram</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajeswari</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kulkarni</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kulkarni</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranganath</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramadevi</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hariharan</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girisha</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <article-title>Novel and recurrent mutations in WISP3 and an atypical phenotype.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2015</year>
                <volume>167</volume>
                <fpage>2481</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">25988854</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.dalal.2012.2820">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dalal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhavani</surname>
                    <given-names>G SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Togarrati</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bierhals</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nandineni</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danda</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vijayan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gowrishankar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phadke</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bidchol</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rao</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nampoothiri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutsche</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girisha</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <article-title>Analysis of the WISP3 gene in Indian families with progressive pseudorheumatoid dysplasia.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>2820</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22987568</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.delague.2005.118">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Delague</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chouery</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corbani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghanem</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aamar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy-Lahad</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;garban&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Molecular study of WISP3 in nine families originating from the Middle-East and presenting with progressive pseudorheumatoid dysplasia: identification of two novel mutations, and description of a founder effect.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2005</year>
                <volume>138A</volume>
                <fpage>118</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">16152649</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.garcia_segarra.2012.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garcia Segarra</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mittaz</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos-Xavier</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartels</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuysuz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alanay</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cimaz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Rocco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duba</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elcioglu</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forzano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hospach</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilic</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuemmerle-Deschner</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mrusek</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nampoothiri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obersztyn</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pauli</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selicorni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Utine</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>The diagnostic challenge of progressive pseudorheumatoid dysplasia (PPRD): a review of clinical features, radiographic features, and WISP3 mutations in 63 affected individuals.</article-title>
                <source>Am J Med Genet C Semin Med Genet.</source>
                <year>2012</year>
                <volume>160C</volume>
                <fpage>217</fpage>
                <lpage>29</lpage>
                <pub-id pub-id-type="pmid">22791401</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.hurvitz.1999.94">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hurvitz</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suwairi</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Shanti</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roudier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holderbaum</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pauli</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herd</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>EV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rezai-Delui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legius</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Alami</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahabri</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia.</article-title>
                <source>Nat Genet.</source>
                <year>1999</year>
                <volume>23</volume>
                <fpage>94</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10471507</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.pennica.1998.14717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pennica</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swanson</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welsh</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roy</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawrence</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brush</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taneyhill</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deuel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lew</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melhem</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finley</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quirke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goddard</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hillan</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurney</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botstein</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <article-title>WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>1998</year>
                <volume>95</volume>
                <fpage>14717</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">9843955</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.sen.2004.488">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldring</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lotz</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carson</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <article-title>WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes.</article-title>
                <source>Arthritis Rheum.</source>
                <year>2004</year>
                <volume>50</volume>
                <fpage>488</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">14872491</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.wang.2013">
              <mixed-citation publication-type="other">Wang M, Man XF, Liu YQ, Liao EY, Shen ZF, Luo XH, Guo LJ, Wu XP, Zhou HD. Dysfunction of collagen synthesis and secretion in chondrocytes induced by wisp3 mutation. Int J Endocrinol. 2013;2013:679763.</mixed-citation>
            </ref>
            <ref id="ppr-dysp.REF.wynnedavies.1982.442">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wynne-Davies</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ansell</surname>
                    <given-names>BM</given-names>
                  </name>
                </person-group>
                <article-title>Spondylo-epiphysial dysplasia tarda with progressive arthropathy. A "new" disorder of autosomal recessive inheritance.</article-title>
                <source>J Bone Joint Surg Br.</source>
                <year>1982</year>
                <volume>64</volume>
                <fpage>442</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">6807993</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.zhou.2007.985">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bu</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>YQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>LQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>QY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ni</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liao</surname>
                    <given-names>EY</given-names>
                  </name>
                </person-group>
                <article-title>Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation.</article-title>
                <source>J Mol Med (Berl)</source>
                <year>2007</year>
                <volume>85</volume>
                <fpage>985</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">17483925</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="ppr-dysp.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="ppr-dysp.Suggested_Reading.reflist0">
            <ref id="ppr-dysp.REF.alawadi.1984.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Awadi</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farag</surname>
                    <given-names>TI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naguib</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Khalifa</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuschieri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosny</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zahran</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Ansari</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <article-title>Spondyloepiphyseal dysplasia tarda with progressive arthropathy.</article-title>
                <source>J Med Genet.</source>
                <year>1984</year>
                <volume>21</volume>
                <fpage>193</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">6431106</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.ehl.2004.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ehl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uhl</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonafe</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirchhoff</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Clinical, radiographic, and genetic diagnosis of progressive pseudorheumatoid dysplasia in a patient with severe polyarthropathy.</article-title>
                <source>Rheumatol Int.</source>
                <year>2004</year>
                <volume>24</volume>
                <fpage>53</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12819927</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.ekbote.2013.582">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ekbote</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danda</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madhuri</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibikote</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>A descriptive analysis of 14 cases of progressive-psuedorheumatoid-arthropathy of childhood from south India: review of literature in comparison with juvenile idiopathic arthritis.</article-title>
                <source>Semin Arthritis Rheum.</source>
                <year>2013</year>
                <volume>42</volume>
                <fpage>582</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23270760</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.elshanti.1998.251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>el-Shanti</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semina</surname>
                    <given-names>EV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beutow</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherpbier</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>al-Alami</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Assignment of gene responsible for progressive pseudorheumatoid dysplasia to chromosome 6 and examination of COL10A1 as candidate gene.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>1998</year>
                <volume>6</volume>
                <fpage>251</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9781029</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.elshanti.1997.559">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>el-Shanti</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Omari</surname>
                    <given-names>HZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qubain</surname>
                    <given-names>HI</given-names>
                  </name>
                </person-group>
                <article-title>Progressive pseudorheumatoid dysplasia: report of a family and review.</article-title>
                <source>J Med Genet.</source>
                <year>1997</year>
                <volume>34</volume>
                <fpage>559</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">9222963</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.fischer.1998.60">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavek</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandiedonck</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruls</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkatip</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prud'homme</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weissenbach</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Genetic linkage of progressive pseudorheumatoid dysplasia to a 3-cM interval of chromosome 6q22.</article-title>
                <source>Hum Genet.</source>
                <year>1998</year>
                <volume>103</volume>
                <fpage>60</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9737778</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.rezaidelui.1994.411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rezai-Delui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamoori</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadri-Mahvelati</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noori</surname>
                    <given-names>NM</given-names>
                  </name>
                </person-group>
                <article-title>Progressive pseudorheumatoid chondrodysplasia: a report of nine cases in three families.</article-title>
                <source>Skeletal radiol.</source>
                <year>1994</year>
                <volume>23</volume>
                <fpage>411</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">7992106</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.spranger.1983.399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albert</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schilling</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartsocas</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Progressive pseudorheumatoid arthropathy of childhood (PPAC): a hereditary disorder simulating juvenile rheumatoid arthritis.</article-title>
                <source>Am J Med Genet.</source>
                <year>1983</year>
                <volume>14</volume>
                <fpage>399</fpage>
                <lpage>401</lpage>
                <pub-id pub-id-type="pmid">6837637</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.spranger.2012">
              <mixed-citation publication-type="book">Spranger JW, Brill PW, Nishimura G, Superti-Furga A, Unger S. Progressive pseudorheumatoid chondrodysplasia. <italic toggle="yes">Bone Dysplasias, An Atlas of Genetic Disorders of Skeletal Development.</italic> 3 ed. New York, NY: Oxford University Press; 2012:182-4</mixed-citation>
            </ref>
            <ref id="ppr-dysp.REF.sun.2012.e38643">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xing</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meng</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <article-title>Novel and recurrent mutations of WISP3 in two Chinese families with progressive pseudorheumatoid dysplasia.</article-title>
                <source>PloS one.</source>
                <year>2012</year>
                <volume>7</volume>
                <fpage>e38643</fpage>
                <pub-id pub-id-type="pmid">22685593</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.teebi.1986.189">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Teebi</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Awadi</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <article-title>Spondyloepiphyseal dysplasia tarda with progressive arthropathy: a rare disorder frequently diagnosed among Arabs.</article-title>
                <source>J Med Genet.</source>
                <year>1986</year>
                <volume>23</volume>
                <fpage>189</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">3712405</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.temiz.2011.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Temiz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozbek</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sangun</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mungan</surname>
                    <given-names>NO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuksel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topaloglu</surname>
                    <given-names>AK</given-names>
                  </name>
                </person-group>
                <article-title>A homozygous recurring mutation in WISP3 causing progressive pseudorheumatoid arthropathy.</article-title>
                <source>J Pediatr Endocrinol Metab.</source>
                <year>2011</year>
                <volume>24</volume>
                <fpage>105</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21528827</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.ye.2012.190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qiu</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>YF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gong</surname>
                    <given-names>ZW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>XF</given-names>
                  </name>
                </person-group>
                <article-title>Patients with progressive pseudorheumatoid dysplasia: from clinical diagnosis to molecular studies.</article-title>
                <source>Mol Med Rep.</source>
                <year>2012</year>
                <volume>5</volume>
                <fpage>190</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21993478</pub-id>
              </element-citation>
            </ref>
            <ref id="ppr-dysp.REF.yue.2009.547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>ZL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <article-title>Identification of novel mutations in WISP3 gene in two unrelated Chinese families with progressive pseudorheumatoid dysplasia.</article-title>
                <source>Bone.</source>
                <year>2009</year>
                <volume>44</volume>
                <fpage>547</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">19064006</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="ppr-dysp.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="ppr-dysp.Acknowledgments">
          <title>Acknowledgments</title>
          <list list-type="bullet">
            <list-item>
              <p>Indian Council of Medical Research- Clinical and molecular evaluation of inherited arthropathies and multiple vertebral segmentation defects (BMS 54/2/2013)</p>
            </list-item>
            <list-item>
              <p>Department of Science and Technology- Application of autozygosity mapping and exome sequencing to identify genetic basis of disorders of skeletal development (SB/SO/HS/005/2014)</p>
            </list-item>
          </list>
        </sec>
        <sec id="ppr-dysp.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>25 November 2015 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>30 June 2015 (kmg) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="ppr-dysp.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Hands of individuals show progressive swelling and limited range of movement of the interphalangeal joints.A. Age 5 yearsB. Age 7 yearsC. Age 11 yearsD. Age 12 yearsE. Age 13 yearsF. Age 15 yearsG. Age 16 yearsH. Age 17 yearsI. Age 23 years</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ppr-dysp-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="ppr-dysp.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Radiographs of hands show large epiphyses and widened metaphyses of metacarpals and phalanges. Joint space is also reduced. A. Age 5 yearsB. Age 6 yearsC. Age 7 yearsD. Age 8 yearsE. Age 9 yearsF. Age 10 yearsG. Age 11 yearsH. Age 12 yearsI. Age 13 yearsJ. Age 15 yearsK. Age 16 yearsL. Age 17 yearsM. Age 30 yearsN. Age 50 years</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ppr-dysp-Image002" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="ppr-dysp.F3" orientation="portrait">
          <label>Figure 3. </label>
          <caption>
            <p>Pelvic radiographs demonstrate reduced hip joint spaces, large capital femoral epiphyses, short and broad femoral necks and irregular acetabular roofs. Iliac crests also are irregular in adolescence. A. Age 5 yearsB. Age 7 yearsC. Age 8 yearsD. Age 9 yearsE. Age 11 yearsF. Age 12 yearsG. Age 13 yearsH. Age 15 yearsI. Age 16 yearsJ. Age 19 yearsK. Age 30 yearsL. Age 50 years</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ppr-dysp-Image003" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="ppr-dysp.F4" orientation="portrait">
          <label>Figure 4. </label>
          <caption>
            <p>Progressive platyspondyly due to erosion of the superior and inferior articular cartilagesA. Age 5 yearsB. Age 7 yearsC. Age 9 yearsD. Age 11 yearsE. Age 13 yearsF. Age 15 yearsG. Age 16 yearsH. Age 17 yearsI. Age 30 yearsJ. Age 50 years</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ppr-dysp-Image004" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
